SUBSCRIBE
SUBSCRIBE

CNS Pharmaceuticals, Inc.

NEWS
Image of Houston downtown park and skyline in the morning
Business
Houston’s Life Sciences Scene Continues Boosting Its Reputation
While Houston isn’t yet on the same level as major life sciences hubs, it has plenty to offer and room to grow, according to CNS Pharmaceuticals, RadioMedix and Greater Houston Partnership executives.
March 13, 2025
 · 
6 min read
 · 
Angela Gabriel
IN THE PRESS
Press Releases
CNS Pharmaceuticals’ Chief Medical Officer, Sandra Silberman, MD, PhD to Present at the 2025 Brain Tumor Biotech Summit
June 5, 2025
 · 
4 min read
Press Releases
CNS Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 16, 2025
 · 
6 min read
Press Releases
CNS Pharmaceuticals Acquires Orphan Drug Designation for Novel, Late Stage Abeotaxane, TPI 287
May 14, 2025
 · 
5 min read
Press Releases
CNS Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
May 13, 2025
 · 
4 min read
Press Releases
CNS Pharmaceuticals Reports Full Year 2024 Financial Results
April 1, 2025
 · 
8 min read
Press Releases
CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme
March 26, 2025
 · 
8 min read
Press Releases
CNS Pharmaceuticals Provides Update on Current Cash Position and NASDAQ Listing
February 27, 2025
 · 
4 min read
Press Releases
CNS Pharmaceuticals to Present at the 18th Annual European Life Sciences CEO Forum
February 20, 2025
 · 
2 min read
Press Releases
CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
February 19, 2025
 · 
3 min read
Press Releases
CNS Pharmaceuticals Announces Reverse Stock Split
February 19, 2025
 · 
4 min read
Load More
JOBS